InDex Pharmaceuticals to attend the ECCO 2023 congress
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company will attend the annual congress of the European Crohn's and Colitis...
Source: prnewswire.com
Page 3 - Induction Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Induction Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Induction Study Today - Breaking & Trending Today
InDex Pharmaceuticals provides complementary information on the phase III program CONCLUDE with cobitolimod
STOCKHOLM, Feb. 14, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) is today making a presentation with CEO Jenny Sundqvist available in light of the press release issued January
Source: finanznachrichten.de
New TREMFYA® (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2b QUASAR Induction Study 1 in adults with...
Source: prnewswire.com
Galapagos NV: Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
Source: finanznachrichten.de
Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
Source: investegate.co.uk